News & Insights
Expertise
Generative AI in the Newsroom: Friend or Foe?: A Panel Discussion Hosted by FleishmanHillard
June 3, 2024
The Latest
Expertise
Is the U.S. Approval Process for New Medicines Fundamentally Changing?
April 17, 2025
Expertise
Tariffs: No Pause for the Weary but Potential for the Wise
April 16, 2025
Expertise
Three Ps to Future-Proofing Tech Integration in Communications: Takeaways from EDS’ CIO & CISOxNewYork Conference
At this year’s EDS CIO & CISOxNewYork event, one theme cut through the jargon and hype:…
April 11, 2025
Expertise
Stability with an Edge: A Report on China’s 2025 Economic Priorities
March 21, 2025
Expertise
New Report: The Cultural Forces Shaping How Gen Z Shop Today
March 19, 2025
Expertise
Beauty Reckoning: Influence in an Unregulated Creator Hype Cycle
March 13, 2025
Categories
Filter by Locations
All Locations
Expertise
Is the U.S. Approval Process for New Medicines Fundamentally Changing?
April 17, 2025
Expertise
Tariffs: No Pause for the Weary but Potential for the Wise
April 16, 2025
Expertise
Three Ps to Future-Proofing Tech Integration in Communications: Takeaways from EDS’ CIO & CISOxNewYork Conference
At this year’s EDS CIO & CISOxNewYork event, one theme cut through the jargon and hype: clarity. As CIOs and CISOs grapple with the expanding role of AI and emerging…
April 11, 2025
Expertise
Stability with an Edge: A Report on China’s 2025 Economic Priorities
March 21, 2025
Expertise
New Report: The Cultural Forces Shaping How Gen Z Shop Today
March 19, 2025
Expertise
Beauty Reckoning: Influence in an Unregulated Creator Hype Cycle
March 13, 2025
Expertise
The Transatlantic Toll: U.S.-EU Pharma at Risk Under Trump’s Tariffs
March 11, 2025
News
FleishmanHillard Hires Jim Joseph as Global Head of Brand Impact
March 4, 2025
